Related Experiment Video
Updated: Aug 5, 2026

Quantification of Oculomotor Responses and Accommodation Through Instrumentation and Analysis Toolboxes
Published on: March 3, 2023
Keeping an eye on vision: new tools to preserve sight and quality of life. A roundtable discussion, Part 2
R N Butler1, E E Faye, E Guazzo
1Department of Geriatrics and Adult Development, Mount Sinai Medical Center, New York, USA.
Abstract:
Research is pointing the way to new therapies for the eye diseases of aging. A gene that appears related to glaucoma has been identified, and a safe and effective inhibitor for aldose reductase is being sought for patients with diabetic retinopathy. Refinements in cataract surgery continue to improve the high success rate of this procedure. Physicians can educate their patients to participate in vision protection, through control of blood sugars, compliance with glaucoma medications, and the use of the Amsler grid by those at risk for macular degeneration. When vision cannot be corrected to the normal range, low vision rehabilitation offers magnification and new high-tech devices for optimizing independent patient function.
Insights
New therapies are emerging for age-related eye diseases like glaucoma and diabetic retinopathy. Patient education and low vision rehabilitation are key to preserving sight and independence.
Area of Science:
- Ophthalmology
- Geriatric Medicine
- Genetics
Background:
- Aging populations face increasing prevalence of eye diseases.
- Diabetic retinopathy, glaucoma, and cataracts are leading causes of vision loss.
- Current treatments aim to manage symptoms and slow disease progression.
Purpose of the Study:
- To review current research and therapeutic strategies for common age-related eye diseases.
- To highlight advancements in surgical procedures and pharmacological interventions.
- To emphasize the role of patient education and low vision rehabilitation.
Main Methods:
- Literature review of recent studies on eye disease therapies.
- Analysis of genetic research related to glaucoma.
- Evaluation of aldose reductase inhibitors for diabetic retinopathy.
- Assessment of advancements in cataract surgery techniques.
- Review of low vision aids and rehabilitation strategies.
Main Results:
- Identification of a potential glaucoma-related gene.
- Ongoing search for effective aldose reductase inhibitors for diabetic retinopathy.
- Continued improvement in cataract surgery success rates.
- Established importance of patient-led vision protection measures.
- Development of advanced low vision rehabilitation tools.
Conclusions:
- Emerging therapies offer new hope for age-related eye conditions.
- Multifaceted approaches including medical, surgical, and rehabilitative interventions are crucial.
- Patient engagement in managing chronic conditions like diabetes and glaucoma is vital for vision preservation.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Accessory Structures of the Eye
Photoreceptors and Visual Pathways
Diabetic Retinopathy

